Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical Limited has announced the purchase of 18.336 million shares under its Share Incentive Scheme, initiated by its subsidiary Chia Tai Tianqing. The shares, bought for approximately HKD 50.54 million, represent about 0.10% of the existing shares, at an average price of HKD 2.76 each. This move is aimed at rolling out share-based incentives to selected participants, with further purchases and grants to be determined at the discretion of Chia Tai Tianqing’s board.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
